av Aina Rengmark | okt 11, 2022
Business opportunity Scientists at Oslo University Hospital and the University of Oslo (Norway) have developed a novel metastasis-oriented test and companion diagnostic to predict treatment for the subgroup of patients with the poorest survival after a diagnosis with...
av Lise Rødsten | okt 20, 2021
BUSINESS OPPORTUNITY Scientists at Oslo University Hospital are developing a urine based test, addressing a major unmet need for non-invasive detection and monitoring of bladder cancer. Bladder cancer carries the highest per- lifetime, per-patient cost of any type of...
av Lise Rødsten | sep 3, 2021
BUSINESS OPPORTUNITY Scientists at Oslo University Hospital and University of Oslo have identified a repertoire of celiac disease (CeD) associated T-cell receptors which preliminary data indicate could have a potential as a diagnostic method for CeD. This research is...
av Aina Rengmark | mai 27, 2021
Business opportunity Leading scientists and clinicians at the Akershus University Hospital (Norway) have identified a mitochondrial DNA variant to predict metastatic progression of rectal cancer. High rates of systemic failure after curative-intent therapy in locally...
av Janncike Kristoffersen | aug 5, 2020
Business opportunity Leading scientists at the Cancer Registry of Norway and Oslo University Hospital have identified prediagnostic serum RNA biomarkers for early detection of lung cancer (LC). These biomarkers can be used in lung cancer screening of high-risk...
